• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAR
Click for more information
2.17% 23.5¢

PARADIGM BIOPHARMACEUTICALS LIMITED.. - Charts / Financials

Market Cap $82.20M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Paradigm Biopharmaceuticals Limited is a late-stage drug development company. The Company... Paradigm Biopharmaceuticals Limited is a late-stage drug development company. The Company is engaged in discovering, developing, and delivering pharmaceutical therapies. It is focused on the development of injectable pentosan polysulfate sodium (iPPS/PPS) for the treatment of osteoarthritis (OA) and mucopolysaccharidosis (MPS). Pentosan polysulfate sodium is a semi-synthetic drug manufactured from the wood chips of European beech trees. Extracted glucurono-xylans are sulfated to produce a negatively charged product that mimics glycosaminoglycans (GAGs). It develops PPS under the brand name Zilosul. PPS also inhibits the synthesis of the metalloproteinase, MMP-3 (Troeberg) involved in degrading cartilage. PPS also include treatment of joint function, mobility, and pain in patients with MPS; treating alphavirus-induced arthralgia (such as Ross River virus and Chikungunya); chronic heart failure (HF) and acute respiratory distress syndrome (ARDS).More

refresh Created with Sketch. REFRESH
Last update - 15.48pm 23/08/2024 (20 minute delay) ?
Day
Open 23.5¢   Day High 24.0¢   Day Low 22.5¢
Daily Volume 801877
Bids   Sellers
Number Price Volume   Number Price Volume
4 23.0¢ 33599   1 23.5¢ 65498

Directors & Senior Management

Mr. Paul Rennie Executive Chairman of the Board, Managing Director
Ms. Abby Macnish Niven Interim Chief Financial Officer, Company Secretary
Dr. Donna Skerrett Executive Director, Chief Medical Officer
Mr. Matthew James Fry Non-Executive Director
Mr. Amos Meltzer Non-Executive Independent Director

Data source: Refinitiv

(20min delay)
Last
23.5¢ 		Change
0.005(2.17%) 		Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 24.0¢ 22.5¢ $186.1K 801.8K

Buyers (Bids)

No. Vol. Price($)
4 33599 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 65498 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
Last
23.5¢ 		  Change
0.005 ( 0.00 %)
Open High Low Volume
23.0¢ 24.0¢ 22.0¢ 241967
Last updated 15.48pm 23/08/2024 ?

Top Stories

Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt

Noronex Limited (ASX:NRX) has kicked off a gravity EM survey at the Damara project in Namibia – part of its earn-in deal with South32.
Raiden gears up for exploration in final quarter of 2024 Raiden Resources Ltd - which is exploration for a multiplicity of minerals in the Pilbara region of WA - is looking ahead to a busy schedule.
How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign Strategic Energy Resources is 4 holes into a 40-hole RC drill campaign at its Achilles 1 copper-gold target in the Cobar Basin of NSW.
IPH raises $100M to buy up Canadian IP firm Bereskin & Parr IPH Ltd has raised $100 million in an institutional placement to support the acquisition, while also launching a share purchase plan.
Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions Given the recent fall in iron ore prices below the $100 mark, now might be the time to buy into specialised stocks in the materials sector.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.